Overexpression of SHARPIN in breast cancer is correlated with ERα protein levels, and that SHARPIN can promote breast cancer development by regulating the ubiquitination of ERα proteins, during which SHARPIN is not involved in regulating gene expression. This evidence concerns the gene SHARPIN and breast carcinoma.